As these results suggest a potentially divergent role of Hmgcs2-mediated ketogenesis in liver fibrosis and inflammation in contrast to lipid and glucose metabolism, careful assessments of the benefits and limitations of ketogenesis-mediated treatments against fatty liver diseases will be necessary. The gene discussed is HMGCS2; the disease is fatty liver disease.